News | September 28, 2010

Downloadable Software Could Cut Risk of ICD Shocks

September 28, 2010 - Software downloaded during a routine office visit cuts the risk of inappropriate shocks by 50 percent for patients with implantable cardioverter defibrillators (ICD), according to research reported in Circulation: Journal of the American Heart Association.

Implanted defibrillators monitor the heart's electrical activity and deliver a shock to reset the heart to a normal rhythm if the pulse becomes too rapid and unable to sustain life. But if the lead wires connecting the device to the heart muscle break, the defibrillator may interpret rapid electrical signals caused by the fracture as coming from the heart - delivering one or more unnecessary and often painful shocks.

Although all leads can fracture, the most widely sold model — the Sprint Fidelis, used with many different defibrillator designs and removed from the market in October 2007 — had a much higher rate of breaks and inappropriate shocks. Downloadable Lead Integrity Alert (LIA) software monitors Fidelis leads for evidence of suspicious electrical signals, alerting the patient and recalibrating the device to make a shock less likely if a fracture is suspected.

"Hundreds of patients have been saved from unnecessary shocks by software that is safe and can be painlessly downloaded in one minute during a standard defibrillator check," said Charles D. Swerdlow, M.D., lead author of the study and a cardiac electrophysiologist at the Cedars Sinai Heart Institute in Los Angeles and clinical professor of medicine at the University of California, Los Angeles.

Researchers compared the experience of patients prior to their undergoing surgery to replace fractured leads, including 213 who had received standard daily monitoring and 213 monitored with the addition of the downloadable LIA.

They found:

• One or more inappropriate shocks were delivered to 70 percent of the patients who received standard monitoring, but only 38 percent of the patients with LIA (a 46 percent reduction in risk).

• Five or more inappropriate shocks were delivered to 50 percent of the patients who received standard monitoring, but only 25 percent of patients with LIA (a 50 percent reduction in risk).

• 72 percent of patients with LIA had no inappropriate shock, or had at least three days warning prior to an inappropriate shock, whereas this was observed in only 50 percent of those who received standard monitoring.

The study is the first to demonstrate that the downloadable LIA software dramatically decreases the chance of unnecessary shocks in real patients. The results reveal the possibility of making other improvements to devices while they're implanted, researchers said.

Medtronic, an ICD manufacturer, funded the study.

For more information: www.americanheart.org

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init